Thomas Craig is Director at IDEXX LABORATORIES INC /DE (IDXX). They have made 13 open-market trades across 1 company since 2008, most recently 2017-04-28.
CIK 0001184156
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IDXX | 24,471 | $17.1M |
Shares reported on the most recent Form 4, priced at the 2017-05-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IDXX | SELL | 2016-11-23 | 2016-11-28 | $120.06 | $1.0M | -0.8% | -1.7% | +19.9% |
| IDXX | SELL | 2016-02-09 | 2016-02-11 | $69.52 | $286K | +5.8% | +14.8% | +27.9% |
| IDXX | SELL | 2015-11-30 | 2015-12-02 | $70.28 | $492K | -6.8% | -1.7% | +4.3% |
| IDXX | SELL | 2015-08-31 | 2015-09-02 | $71.77 | $57K | -6.8% | -1.7% | -1.7% |
| IDXX | SELL | 2015-08-18 | 2015-08-20 | $79.41 | $230K | -6.8% | -1.7% | -1.7% |
| IDXX | SELL | 2015-02-05 | 2015-02-09 | $156.57 | $115K | -6.8% | -1.7% | -1.7% |
| IDXX | SELL | 2015-02-03 | 2015-02-05 | $157.03 | $345K | -6.8% | -1.7% | -1.7% |
| IDXX | SELL | 2014-11-13 | 2014-11-17 | $152.45 | $762K | -6.8% | -1.7% | -1.7% |
| IDXX | SELL | 2014-02-19 | 2014-02-21 | $125.42 | $602K | -6.8% | -1.7% | -1.7% |
| IDXX | SELL | 2012-09-14 | 2012-09-18 | $99.29 | $794K | -6.8% | -1.7% | -1.7% |
| IDXX | SELL | 2011-04-26 | 2011-04-28 | $80.33 | $562K | -6.8% | -1.7% | -1.7% |
| IDXX | SELL | 2008-03-14 | 2008-03-18 | $50.14 | $1.5M | -6.8% | -1.7% | -1.7% |
| IDXX | SELL | 2008-03-14 | 2008-03-18 | $50.58 | $116K | -6.8% | -1.7% | -1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.